Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Nursing Outlook
|
August 6, 2022
Redesigning culturally tailored intervention in the precision health era: Self-management science context
Miyong T Kim, Elizabeth M Heitkemper, Emily T Hébert, et al.
Clinical and Translational Science
|
December 9, 2024
Translational findings support regimen selection for first-in-human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer
Min Zhu, Priyanka Madia, Alison Crawford, et al.
Cancer Research
|
March 5, 2014
Immunosurveillance by antiangiogenesis: tumor growth arrest by T cell-derived thrombospondin-1
Keri L Schadler, Erika J Crosby, Alice Yao Zhou, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition
|
April 29, 2026
Developmental follow-up, surveillance and support at the age of 4 years: a best practice guide from the British Association for Neonatal Neurodevelopmental Follow-Up
Katie Mckinnon, Anusha Arasu, Joanne Beckmann, et al.
Nature Immunology
|
May 31, 2011
Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection
Charlly Kao, Kenneth J Oestreich, Michael A Paley, et al.
Cancer Immunology Research
|
March 19, 2020
A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB Costimulation
Danica Chiu, Richard Tavaré, Lauric Haber, et al.
Nature
|
May 24, 2013
Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria
Matthew R Hepworth, Laurel A Monticelli, Thomas C Fung, et al.
Nature Medicine
|
October 5, 2010
Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF
Michael Quigley, Florencia Pereyra, Björn Nilsson, et al.
Science Translational Medicine
|
June 21, 2019
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer
Alison Crawford, Lauric Haber, Marcus P Kelly, et al.
Cell Reports. Medicine
|
September 26, 2024
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies
Jiaxi Wu, Nicolin Bloch, Aaron Y Chang, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Nursing Outlook
|
August 6, 2022
Redesigning culturally tailored intervention in the precision health era: Self-management science context
Miyong T Kim, Elizabeth M Heitkemper, Emily T Hébert, et al.
Clinical and Translational Science
|
December 9, 2024
Translational findings support regimen selection for first-in-human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer
Min Zhu, Priyanka Madia, Alison Crawford, et al.
Cancer Research
|
March 5, 2014
Immunosurveillance by antiangiogenesis: tumor growth arrest by T cell-derived thrombospondin-1
Keri L Schadler, Erika J Crosby, Alice Yao Zhou, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition
|
April 29, 2026
Developmental follow-up, surveillance and support at the age of 4 years: a best practice guide from the British Association for Neonatal Neurodevelopmental Follow-Up
Katie Mckinnon, Anusha Arasu, Joanne Beckmann, et al.
Nature Immunology
|
May 31, 2011
Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection
Charlly Kao, Kenneth J Oestreich, Michael A Paley, et al.
Cancer Immunology Research
|
March 19, 2020
A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB Costimulation
Danica Chiu, Richard Tavaré, Lauric Haber, et al.
Nature
|
May 24, 2013
Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria
Matthew R Hepworth, Laurel A Monticelli, Thomas C Fung, et al.
Nature Medicine
|
October 5, 2010
Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF
Michael Quigley, Florencia Pereyra, Björn Nilsson, et al.
Science Translational Medicine
|
June 21, 2019
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer
Alison Crawford, Lauric Haber, Marcus P Kelly, et al.
Cell Reports. Medicine
|
September 26, 2024
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies
Jiaxi Wu, Nicolin Bloch, Aaron Y Chang, et al.
Page
of 4